Eyenovia Inc (EYEN)
0.0942
0.00 (0.00%)
USD |
NASDAQ |
Dec 27, 16:00
0.0927
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Research and Development Expense (Quarterly): 3.472M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
TFF Pharmaceuticals Inc | 1.820M |
Johnson & Johnson | 4.952B |
Merck & Co Inc | 5.862B |
Aptevo Therapeutics Inc | 3.103M |
Amneal Pharmaceuticals Inc | 63.06M |